Type I IFN has been demonstrated to have major regulatory effects on the outcome of
bacterial infections. To assess the effects of exogenously induced type I IFN on the outcome of
Mycobacterium tuberculosis infection, we treated pathogen-exposed mice intranasally with
polyinosinic-polycytidylic acid condensed with poly-
l-lysine and
carboxymethylcellulose (
Poly-ICLC), an agent designed to stimulate prolonged, high-level production of type I IFN.
Drug-treated, M.
tuberculosis-infected WT mice, but not mice lacking IFN-alphabeta receptor 1 (IFNalphabetaR; also known as IFNAR1), displayed marked elevations in lung bacillary loads, accompanied by widespread pulmonary
necrosis without detectable impairment of Th1 effector function. Importantly, lungs from
Poly-ICLC-treated M.
tuberculosis-infected mice exhibited a striking increase in CD11b+F4/80+Gr1int cells that displayed decreased MHC II expression and enhanced bacterial levels relative to the same subset of cells purified from infected, untreated controls. Moreover, both the
Poly-ICLC-triggered pulmonary recruitment of the CD11b+F4/80+Gr1int population and the accompanying exacerbation of
infection correlated with type I IFN-induced upregulation of the
chemokine-encoding gene Ccl2 and were dependent on host expression of the
chemokine receptor CCR2. The above findings suggest that
Poly-ICLC treatment can detrimentally affect the outcome of M.
tuberculosis infection, by promoting the accumulation of a permissive myeloid population in the lung. In addition, these data suggest that agents that stimulate type I IFN should be used with caution in patients exposed to this pathogen.